Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 11:8:455.
doi: 10.3389/fphar.2017.00455. eCollection 2017.

MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor

Affiliations

MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor

Drew J Puxty et al. Front Pharmacol. .

Abstract

Previous research has shown that a single dose of MDMA induce a dissociative state, by elevating feelings of depersonalization and derealization. Typically, it is assumed that action on the 5-HT2A receptor is the mechanism underlying these psychedelic experiences. In addition, other studies have shown associations between dissociative states and biological parameters (heart rate, cortisol), which are elevated by MDMA. In order to investigate the role of the 5-HT2 receptor in the MDMA-induced dissociative state and the association with biological parameters, a placebo-controlled within-subject study was conducted including a single oral dose of MDMA (75 mg), combined with placebo or a single oral dose of the 5-HT2 receptor blocker ketanserin (40 mg). Twenty healthy recreational MDMA users filled out a dissociative states scale (CADSS) 90 min after treatments, which was preceded and followed by assessment of a number of biological parameters (cortisol levels, heart rate, MDMA blood concentrations). Findings showed that MDMA induced a dissociative state but this effect was not counteracted by pre-treatment with ketanserin. Heart rate was the only biological parameter that correlated with the MDMA-induced dissociative state, but an absence of correlation between these measures when participants were pretreated with ketanserin suggests an absence of directional effects of heart rate on dissociative state. It is suggested that the 5-HT2 receptor does not mediate the dissociative effects caused by a single dose of MDMA. Further research is needed to determine the exact neurobiology underlying this effect and whether these effects contribute to the therapeutic potential of MDMA.

Keywords: 5-HT2 receptor; MDMA; MDMA concentration; cortisol; depersonalization; derealization; dissociative state; heart rate.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Mean (± SE) ratings on the subscales (A) Derealization, (B) Depersonalization, (C) Amnesia of the CADSS and the sum score (D) of the scales, during baseline and 120 and 90 min after pre-treatment and treatment respectively.
FIGURE 2
FIGURE 2
Mean (± SE) plasma concentrations of cortisol in the four treatment conditions, at baseline, before tests (i.e., 90 min after treatment, respectively 120 min after pre-treatment), and after tests (i.e., 150 min after treatment, respectively 180 min after pre-treatment).

Similar articles

Cited by

References

    1. Anneken J. H., Cunningham J. I., Collins S. A., Yamamoto B. K., Gudelsky G. A. (2013). MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. J. Neuroimmune Pharmacol. 8 58–65. 10.1007/s11481-012-9420-x - DOI - PMC - PubMed
    1. Anneken J. H., Gudelsky G. A. (2012). MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus. Neuropharmacology 63 1022–1027. 10.1016/j.neuropharm.2012.07.026 - DOI - PMC - PubMed
    1. Association A. P. (2013). Diagnostic and Statistical Manual of Mental Disorders. Arlington, VA: American Psychiatric Publishing.
    1. Bedi G., Phan K. L., Angstadt M., De wit H. (2009). Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology 207 73–83. 10.1007/s00213-009-1635-z - DOI - PMC - PubMed
    1. Brogden R. N., Sorkin E. M. (1990). Ketanserin. Drugs 40 903–949. 10.2165/00003495-199040060-00010 - DOI - PubMed

LinkOut - more resources